Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Montréal

$30,000.00

Regulation of neutrophil apoptosis throught the pleiotropic receptor FPR2

EF 2014-15

Résumé
Neutrophil granulocytes constitute the first line of defense against infection, but are also capable of inflicting unwanted tissue damage. Recent results from our laboratories contributed to the identification of programmed cell death (apoptosis) of neutrophils as an important control point in the resolution of inflammation. Since neutrophils are exposed to multiple mediators in the inflammatory microenvironment, their fate ultimately depends upon the balance between survival and death-promoting (pro-apoptotic) signalling circuits. Human neutrophils express the receptor named FPR2/ALX, which binds an unusually large number of structurally unrelated molecules (ligands), including the acute-phase reactant serum amyloid A (SAA), the anti-inflammatory lipids lipoxin A4 (LXA4) and aspirin-triggered 15-epi-LXA4, the glucocorticoid-regulated protein annexin A1, and the bacteria-killing peptide CAP18/LL-37. Little is known about how this receptor recognizes and differentially responds to various ligands in regard with life and death decisions. In the current proposal we address this gap in our knowledge. We will study the impact and hierarchy among the above-mentioned ligands on apoptosis of human neutrophils, HL-60 cells (a model system in which genes can easily be manipulated) and neutrophils isolated from genetically modified mice lacking certain signalling molecules. We will combine immunological, biochemical, cell biology and molecular biology techniques to explore the underlying molecular mechanisms. Using mouse models of acute inflammation, we will investigate whether ligand hierarchy translates into modulation of the longevity of neutrophils and outcome of inflammation in vivo. The results from this study will further our understanding of the molecular mechanisms how activation of FPR2/ALX integrates opposing signals that determine the fate of neutrophils. This knowledge may provide a rational basis for designing novel therapeutic approaches aimed at induction of neutrophil apoptosis in inflamed tissues to enhance the resolution of inflammation.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
402286-2011
Name nom
Filep, Janos
Department département
Pathologie et biologie cellulaire
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2011
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Partie
4
Nb partie
5
Application title
Regulation of neutrophil apoptosis throught the pleiotropic receptor FPR2
Keyword
NSERC
Application summary
Neutrophil granulocytes constitute the first line of defense against infection, but are also capable of inflicting unwanted tissue damage. Recent results from our laboratories contributed to the identification of programmed cell death (apoptosis) of neutrophils as an important control point in the resolution of inflammation. Since neutrophils are exposed to multiple mediators in the inflammatory microenvironment, their fate ultimately depends upon the balance between survival and death-promoting (pro-apoptotic) signalling circuits. Human neutrophils express the receptor named FPR2/ALX, which binds an unusually large number of structurally unrelated molecules (ligands), including the acute-phase reactant serum amyloid A (SAA), the anti-inflammatory lipids lipoxin A4 (LXA4) and aspirin-triggered 15-epi-LXA4, the glucocorticoid-regulated protein annexin A1, and the bacteria-killing peptide CAP18/LL-37. Little is known about how this receptor recognizes and differentially responds to various ligands in regard with life and death decisions. In the current proposal we address this gap in our knowledge. We will study the impact and hierarchy among the above-mentioned ligands on apoptosis of human neutrophils, HL-60 cells (a model system in which genes can easily be manipulated) and neutrophils isolated from genetically modified mice lacking certain signalling molecules. We will combine immunological, biochemical, cell biology and molecular biology techniques to explore the underlying molecular mechanisms. Using mouse models of acute inflammation, we will investigate whether ligand hierarchy translates into modulation of the longevity of neutrophils and outcome of inflammation in vivo. The results from this study will further our understanding of the molecular mechanisms how activation of FPR2/ALX integrates opposing signals that determine the fate of neutrophils. This knowledge may provide a rational basis for designing novel therapeutic approaches aimed at induction of neutrophil apoptosis in inflamed tissues to enhance the resolution of inflammation.